Caz Investments »

Design Therapeutics shares owned by Caz Investments

Quarter-by-quarter ownership of Design Therapeutics (DSGN) shares owned by Caz Investments from 13F filings

Historical chart of Caz Investments investment in Design Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Design Therapeutics held by Caz Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Design Therapeutics by Caz Investments

Quarter filed Position value Share count Share price at filing
2024-09-30 $81k 15k 5.40
2024-06-30 $134k 40k 3.35

More positions owned by Caz Investments

P10 Inc-a Common Stock (PX)
Spy P 11/15/2024 480 Option Put Option
Grab Holdings Ltd - Cl A Common Stock (GRAB)
Blue Owl Capital Common Stock (OWL)
Opendoor Technologies Common Stock (OPEN)
Blackstone Common Stock (BX)
Ishares Biotechnology Etf Common Stock (IBB)
Paypal Holdings Common Stock (PYPL)
Jpmorgan Chase & Co Common Stock (JPM)
Ishares Msci Emerging Market Common Stock (EEM)
United States Commodity Inde Common Stock (USCI)
Luminar Technologies Common Stock (LAZR)
Greenlight Capital Re Ltd-a Common Stock (GLRE)
Hagerty Inc-a Common Stock (HGTY)
Dropbox Inc-class A Common Stock (DBX)

View all positions for Caz Investments

Top funds holding Design Therapeutics

Sr One Capital Management
Logos Global Management
BlackRock
Frazier Life Sciences Management
Baker Bros. Advisors
Point72 Asset Management
Tang Capital Management
Vanguard Group
Almitas Capital
FMR
Geode Capital Management
State Street Corporation
Acadian Asset Management
D. E. Shaw & Co
Citadel Advisors

View all funds holding Design Therapeutics